Personalis (PSNL) news
Recent news
Personalis - new task order effective Sept 30, 2026, valued up to $18.30 mln - SEC filing
Personalis, Inc. (NASDAQ: PSNL) has announced a new task order effective September 30, 2026, valued up to $18.30 million, according to a recent SEC filing. The task order is part of the company’s ongoing efforts to expand its clinical testing services and strengthen its position in the precision…
AInvest Wire · Aug 20, 2026Personalis - on Aug 20, received new task order under its contract with U.S. Department of Veterans Affairs for VA MVP
Personalis, Inc. (Nasdaq: PSNL) has received a new task order under its contract with the U.S. Department of Veterans Affairs (VA) for the VA Million Veteran Program (VA MVP), with an approximate value of up to $31 million . This task order was issued following the decision to extend the existing…
AInvest Wire · Aug 20, 2026Personalis shares down 10% after Tempus AI to acquire co for $1.5 bln
Tempus AI Inc. will acquire Personalis in a $1.50 billion all-stock transaction structured as a 100% stock deal, with Personalis shareholders to receive $16.25 per share or an equivalent maximum exchange ratio of 0.3356 Tempus AI shares per Personalis share, marking the latest progress in…
AInvest Wire · Jul 20, 2026Personalis shares down 1.4% premarket after resuming
Personalis, Inc. (NASDAQ: PRLS) shares fell 1.4% in premarket trading on July 20, 2026, following the resumption of trading after a prior market suspension. The stock had been halted earlier in the week due to a regulatory filing related to its financial reporting practices. The resumption of…
AInvest Wire · Jul 20, 2026Tempus AI shares fall 8.5% premarket after co to acquire Personalis in $1.5 bln deal
Tempus AI Inc. (TEMP) shares declined 8.5% in premarket trading on July 20, 2026, following the announcement that the company has agreed to acquire Personalis, a genomic profiling company, in a deal valued at $1.5 billion . The acquisition is intended to enhance Tempus AI’s capabilities in…
AInvest Wire · Jul 20, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.